Medical and economic dimensions linking allergic rhinitis and asthma

Allergy and Asthma Proceedings

Volumn 23, Issue 4, 2002, Pages 223-227

  Blaiss, Michael S ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTHMA; AUSTRALIA; ECONOMICS; HEALTH CARE COST; HUMAN; NEW ZEALAND; PERENNIAL RHINITIS; PREVALENCE; UNITED KINGDOM; UNITED STATES;

ASTHMA; AUSTRALIA; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; NEW ZEALAND; PREVALENCE; RHINITIS, ALLERGIC, PERENNIAL; UNITED STATES;

EID: 0036633191     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Sibbald B, and E Rink. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 46.895-901, 1991.
2. Naclerio R, Allergic rhinitis. N Engl J Med 325:860-869, 1991.
3. Arrighi H M, Maler WC, and Redding GJ. The impack of allergic rhinitis in Seattle school children. J Allergy Clin Immunol 95:192, 1995 (Abs).
4. Sly RM, Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol 82:233-252, 1999.
5. Mannino DR, Roma DM, and Pertowski CA. Surveillance for asthma - United States. 1960-1995. MMWR 47:SS-1, 1998.
6. Beasley R, Crane J, and Lai CK. Prevalence and etiology of asthma. J Allergy Clin Immunol 105(Pt 2):S466-S472, 2000.
7. Attack asthma: why America needs a public health defense system to battle environmental threats, In Pew Environmental Health Commission at the Johns Hopkins School of Public Health. May 2000. At www.healthyamericans.org/resources/reports/asthma.
8. Smith J. Edidemiology and natural history of asthma, allergic rhinitis, and atopic dermatitis (eczema). In Allergy: Principles and Practice. Middleton CRE Jr, Ellis E, Adkinson NF Jr, and Yungiger JW (Eds). St. Louis, MO: Mosby, 891-929, 1988.
9. Kapsali T, Horowitz E, and Diemer F. Rhinitis is ubiquitous in allergic asthmatics. J Allergy Clin Immunol 99:5138, 1997 (Abs)
10. Simons F E R. Allergic rhino-bronchitis: the asthma-allergic rhinitis link. J Allergy Clin Immunol 104:534-540, 1999.
11. Corren J. The impact of allergic rhinitis on bronchial asthma. J Allergy Clin Immunol 101(Pt 2):S352-S356, 1998.
12. Kaufman J, and Wright G. The effect of nasal and nasopharyngeal irritation on airways resistance in man. Am Rev Respir Dis 100:626-630, 1969.
13. Shturman-Ellstein R, Zaballos RJ, and Buckley JM. The beneficial effects of nasal breathing on exercise-induced bronchoconstriction. Am Rev Respir Dis 118:65-73, 1978.
14. Brugman. Increased lower airways responsiveness associated with sinusitis in a rabbit model. Am Rev Respir Dis 147:314-320, 1993.
15. Braunstahl G-J, and Overbeek S. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in the upper and lower airways. J Allergy Clin Immunol 107:469-476, 2001.
16. Braunstahl G, KleinJan A, and Overbeek S Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients Am J Resp Crit Care Med 161:2051-2057, 2000.
17. Watson W T, Becker AB, and Simons FE. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma effect on lower airway responsiveness. J Allergy Clin Immunol 91 (Pt 1):97-101, 1993.
18. Corren J, Ardinoff J, Buchmeier AD, et al. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 90:250-256, 1992.
19. Corren J. The relationship between allergic rhinitis and bronchial asthma. Curr Opin Pulm Med 5:35-37, 1999
20. Spector SL, Nicodemus CF, Corren J, et al. Comparison of the bronchodilatory effects of cetinzine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma. J Allergy Clin Immunol 96:174-181, 1995.
21. Popa VT. Bronchodilating activity of an HI blocker, chlorphenamine. J Allergy Clin Immunol 59.54-63, 1977.
22. Nogrady SG, and Bevan C. Inhaled antihistamines- bronchodilatation and effects on histamine- and methacholine-induced bronchoconstriction. Thorax 33:700-714, 1978.
23. Grant JA, Nicodemus CF, Findley SR, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 95(Pt 1):923-932, 1995.
24. Corren J, Harris AG, Aaronson D, et al. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma J Allergy Clin Immunol 100(Pt 1):781-788, 1997.
25. Meltzer EO, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinius a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 105:917-922, 2000
26. Chang TW. The pharmacological basis of anti-IgE therapy. Nat Biotechnol 18:157-162, 2000.
27. Adelroth E, et al. Recombinant humanized mAb-E25. an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol 106:253-259, 2000.
28. Barnes PJ. Anti-IgE therapy in asthma: rationale and therapeutic potential. Int Arch Allergy Immunol 123:196-204, 2000 (In Process Citation).
29. McMenamin P. Costs of hay fever in the United States in 1990 [see comments]. Ann Allergy 73:35-39, 1994.
30. Ross RN. Allergic rhinitis, an expensive disease for American business. Am J of Man Care 2:285-290, 1996.
31. Malone DC, Lawson KA, Smith DH, et al. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol 99 (Pt 1):22-27, 1997.
32. Mackowiak J. the health and economic impact of rhinitis - a round-table discussion. Am J Manag Care 3:S8-S18, 1997.
33. Weiss KB, Gergen PJ, and Hodgson TA. An economic evaluation of asthma in the United States [see Comments]. N Engl J Med 326:862-866, 1992.
34. Weiss KB, Sullivan SD, and Lyttle CS. Trends in the cost of illness for asthma in the united states, 1985-1994. J Allergy Clin Immunol 106:493-499, 2000 (In Process Citation).
35. Weiss KB, and Sullivan SD. The health economics of asthma and rhintis. I. Assessing the economic impact. J Allergy Clin Immunol 107:3-8, 2001.
36. Smith D, Malone D, and Lawson K. a national estimate of the economic costs of asthma. Am J Respir Crit Care Med 156:787-793, 1997.
37. Lozano P, Sullivan SD, Smith DH. et al. The economic burden of asthma in U.S. children, estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol 104:957-963, 1999.
38. Krahn MD, Berka C, Langlois P, et al. Direct and indirect costs of asthma m Canada, 1990. Can Med Assoc J 154:821-831, 1996.
39. Ray NF, Baraniuk JN, Thamer M, et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses. J Allergy Clin Immunol 103 (Pt 1).401-407, 1999.